Poster Presentation

Thursday, July 12, 2007
9:30 AM - 10:15 AM

Thursday, July 12, 2007
3:15 PM - 4:00 PM
This presentation is part of : Poster Presentation II
Implementing a Change: Switching from Heparin to Saline in Pediatric Peripheral IV Lines; A Pilot Project
Mary L. White, RN, MSN, APRN-BC, McAuley School of Nursing, University of Detroit Mercy, Detroit, MI, USA, Jamie Crawley, MBA, RN, College of Nursing, University of Windsor, Windsor, ON, Canada, and Linda A. Lewandowski, PhD, RN, College of Nursing, Wayne State University/CHildren's Hospital of Michigan, Detroit, MI, USA.
Learning Objective #1: discuss the importance of collaboration between clinical nurses and nurse researchers to identify needs and implement change based on bedside observations.
Learning Objective #2: recognize the empiric data which supports the use of saline instead of heparin in pediatric peripheral IV lines.


Implementing a Change: Switching from Heparin to Saline in Pediatric Peripheral IV Lines; A Pilot Project

Mary L. White, RN, MSN, APRN, BC

University of Detroit Mercy

Jamie L. Crawley,  RN, BSN, BA, MBA/HCM

University of Windsor

Dr. Linda A. Lewandowski, Ph D., RN

Wayne State University




Purpose:  The purpose of this double-blind, random, quasi-experimental design pilot study will be to determine if saline is equal to or more effective than heparin when flushing pediatric peripheral IV lines.  A total of 96 pediatric patients at Children’s Hospital of Michigan will be participating.


Background:  A review of literature supports using saline in pediatric peripheral IV lines.  Reasons cited include decreased pain reported by the patients; decreased nursing time in flushing the lines; lower side effects; cost-effectiveness, and cultural considerations since heparin is made from animal products. An international phone, e-mail, and web-based survey of 36 hospitals found that 28 hospitals use saline (77.7%) in peripheral pediatric IV lines, while Children’s Hospital of Michigan uses heparin.


Methods:  This pilot project will begin in January of 2007.  Criteria for inclusion in the study will be: children between the ages of 4 weeks and 18 years; diabetes pediatric patients who would have a second heplock for lab draws; those children with IV fluids that are at a KVO rate or a rate that is ordered only for maintaining the IV (and not for hydration); those children with renal disease who are on fluid restrictions and have a heplock for lab draws; and those children who need IV antibiotics but do not need the IV fluids for their care.  Excluded from the study will be children on thrombolytic therapy.


Results: To be analyzed at study completion.


Discussion:  Will be based on results.